European Antibiotic Awareness Day: Rates of carbapenem-resistant infections continue to increase in Europe
On the occasion of the 6th European Antibiotic Awareness Day, the European Centre for Disease Prevention and Control (ECDC) is releasing new EU-wide data on antibiotic resistance showing a marked increase of carbapenem-resistant infections.
Antimicrobial resistance remains commonly detected in bacteria in humans, animals and food: EFSA-ECDC report
Bacteria such as Salmonella and Campylobacter, some of the most common causes of food-borne infections, showed significant resistance to common antimicrobials, according to the newly published EFSA-ECDC European Union Summary Report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2012.
Resistance to last-line antibiotics continues to cause concern in Europe
On the occasion of the 7th European Antibiotic Awareness Day, the European Centre for Disease Prevention and Control (ECDC) is releasing its latest EU-wide data on antibiotic resistance (EARS-Net annual report and interactive database).
Combating resistance to last-line antibiotics in the EU still a priority
On the occasion of the 8th European Antibiotic Awareness Day, ECDC is releasing the results of the European Survey of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) on the spread in Europe’s hospitals of bacteria resistant to carbapenems. Survey also shows that national capacity for the containment of CPE in the EU is increasing.
Antimicrobial resistance on the rise in the European Union, ECDC and EFSA warn
Bacteria in humans, food and animals continue to show resistance to the most widely used antimicrobials, says the latest report on antimicrobial resistance in zoonotic bacteria in Europe. Resistance to ciprofloxacin, an antimicrobial that is critically important for the treatment of human infections, continues to be very high in Campylobacter, thus reducing the options for effective treatment of severe foodborne infections. In addition, multi-drug resistant Salmonella bacteria continue to spread across Europe.
Last-line antibiotics are failing
On the occasion of the 9th European Antibiotic Awareness Day, the European Centre for Disease Prevention and Control (ECDC) is releasing its latest EU-wide data on antibiotic resistance and antibiotic consumption.
Antimicrobial resistance remains high – says EU report
The findings in the latest report on antimicrobial resistance (AMR) in bacteria from ECDC and EFSA underline the serious threat AMR poses to public and animal health. Infections caused by bacteria that are resistant to antimicrobials lead to about 25 000 deaths in the EU every year.
Salmonella and Campylobacter show significant levels of resistance to common antimicrobials in humans and animals
Treatment options for some of the most common food-borne infections are decreasing, as types of bacteria (called ‘isolates’) continue to show resistance to antimicrobial drugs.
Cross-border transfer increases patients’ risk of resistant bacteriaArchived
Patient transfer between hospitals and in particular between countries, is a risk factor for the spread of bacteria that are resistant to last-line antibiotics. More specifically, for highly resistant bacteria, like carbapenamase-producing Enterobacteriaceae (CPE), the risk is heightened when patients are transferred from, or have received previous medical care in areas with high rates of bacterial resistance. These are conclusions from a risk assessment produced by ECDC that evaluated the risk to the citizens of Europe, of the spread of CPE through patient transfer between healthcare facilities, with special emphasis on cross-border transfer.
Concerns about future treatment of gonorrhoea in Europe: ECDC issues response planArchived
With more than 32 000 cases, gonorrhoea was the second most commonly reported sexually transmitted infection (STI) in Europe in 2010. As data from the ECDC report Gonococcal antimicrobial susceptibility surveillance in Europe 2010 illustrates, gonococci have become more resistant to common agents for treatment and show reduced susceptibility to newer antibiotics. “This indicates the risk that gonorrhoea may become an untreatable disease in the near future”, stresses ECDC Director Marc Sprenger.